Resmed Is Protected From Trump's Tariffs, Doesn't Plan to Raise Prices -- Interview
Research Alert: CFRA Reiterates Buy Recommendation On Shares Of Resmed Inc.
S&P 500 Futures Fall In Premarket Trading; Texas Instruments, ServiceNow Lead
ResMed Inc To Go Ex-Dividend On May 7th, 2025 With 0.08269 AUD Dividend Per Share
ResMed Price Target Raised 1.8% to A$45.60/Share by Barrenjoey
Express News | Resmed Inc : Piper Sandler Cuts Target Price to $248 From $260
ResMed Shares Jump 8% on Strong Q3 Update
Market Mover | ResMed Shares Surge Over 7% After Reporting Higher Fiscal Q3 Earnings and Revenue
ResMed Inc. (RMD) Q3 2025 Earnings Call Transcript Summary
ResMed Inc Announces New Dividend Distribution for CDIs
ResMed Inc: Resmed Announces Results for the Third Quarter of FY2025
Resmed Inc. Reports 8% Year-Over-Year Revenue Growth and 14% Increase in Operating Profit for Q3 2025
Express News | Resmed Inc. Announces Results for the Third Quarter of Fiscal Year 2025
Press Release: Resmed Inc. Announces Results for the Third Quarter of Fiscal Year 2025
ResMed 3Q Net $365M >RMD
Press Release: Resmed Names Salli Schwartz as Chief Investor Relations Officer
ResMed Is Maintained at Overweight by Keybanc
ResMed Bull Waits on Tariff Mitigation Moves -- Market Talk
ResMed to Maintain Dominant Sleep Apnea Device Market Share, Expected to Deliver Net Cash Balance Sheet, Jarden Research Says
Express News | Resmed Inc : Mizuho Cuts Target Price to $265 From $280